Astrazeneca Shareholders See Significant Shifts as Institutional Investors Make Big Moves

NewEdge Advisors LLC significantly reduced its holdings in Astrazeneca Plc (NYSE:AZN) by 56.8% during the first quarter, according to a recent Form 13F filing with the Securities and Exchange Commission.

The institutional investor sold 50,971 shares, leaving it with 38,841 shares of the company's stock, valued at $7,660,000 as of its most recent filing.

Other large investors also made significant transactions in Astrazeneca during the first quarter. Amundi boosted its holdings by an astonishing 146,574.4%, now owning 15,386,149 shares worth $3,034,456,000 after purchasing an additional 15,375,659 shares.

Janus Henderson Group PLC lifted its position in Astrazeneca by 889.9% during the first quarter and now owns 11,949,424 shares of the company's stock worth $2,319,947,000 after buying an additional 10,742,268 shares.

Royal Bank of Canada boosted its stake in Astrazeneca by 208.6% during the first quarter and now owns 10,386,455 shares of the company's stock worth $2,048,417,000 after buying an additional 7,021,126 shares.